_________
false
ëï-ôééè áéåôøîä áò"î
2
381
CAN-FITE BIOPHARMA LTD
Corporation no:
512022153
4330
Israel Securities Authority
Tel Aviv Stock Exchange
C003
(
Public
)
Reported via MAGNA:
21/02/2023
www.isa.gov.il
www.tase.co.il
Reference:
2023-02-019485
Time of broadcast:
17:54
17:54
Other Report or Announcement
Regulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
On February 21, 2023, Can-Fite BioPharma convened a Special General Meeting of Shareholders, however, the meeting was adjourned for one day at the same time and place due to lack of quorum. Accordingly, the Company’s Special General Meeting of Shareholders will be reconvened on Wednesday, February 22, 2023 at 3.00 p.m. (Israel time) at the Company’s offices located at 10 Bareket Street, Petach Tikva, Israel.
ea174018-6k_canfitebioEDGAR1_Bannerless_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
2023-02-006879
Stock Exchange/Market:
-1
Date of revision of form structure:
21/02/2023
Address:
Bareket
10
,
Petach-Tikva
47190
,
Tel:
03-9241114
,
03-9213501
Fax:
03-9249378
E-mail address:
motti@canfite.co.il
Company site:
www.canfite.com
Previous names of reporting entity:
Name of the Signatory:
FISHMAN PNINA
Position of Signatory in the reporting corporation:
Director, CFO
Name of Employer Company:
Address:
BAR-ON
2
,
HERZLIA
4658084
Telephone:
03-9241114
Facsimile:
03-9249378
E-mail:
pnina@canfite.co.il
2